Ogura, M., Hatake, K., Ando, K., Tobinai, K., Tokushige, K., Ono, C., . . . Vandendries, E. (2012). Phase I study of anti‐CD22 immunoconjugate inotuzumab ozogamicin plus rituximab in relapsed/refractory B‐cell non‐Hodgkin lymphoma. Cancer Sci.

Ogura, Michinori, Kiyohiko Hatake, Kiyoshi Ando, Kensei Tobinai, Kota Tokushige, Chiho Ono, Taro Ishibashi, و Erik Vandendries. "Phase I Study of Anti‐CD22 Immunoconjugate Inotuzumab Ozogamicin Plus Rituximab in Relapsed/refractory B‐cell Non‐Hodgkin Lymphoma." Cancer Sci 2012.

Ogura, Michinori, et al. "Phase I Study of Anti‐CD22 Immunoconjugate Inotuzumab Ozogamicin Plus Rituximab in Relapsed/refractory B‐cell Non‐Hodgkin Lymphoma." Cancer Sci 2012.